Articles tagged "Heart transplant patients"

2018 American Transplant Congress
Kidney Graft Outcomes in Combined Heart-Kidney Transplantation: A UNOS Database Analysis 2000-2015
A. Riaz, O. Adebiyi, D. Mishler, M. Yaqub, T. Taber, A. Sharfuddin.
Indiana University, Indianapolis.
Background: Combined Heart-Kidney Transplantation (CHKT) is the optimal therapy for patients with advanced renal dysfunction. Our aim was to analyze kidney specific graft outcomes in…
2018 American Transplant Congress
Outcomes after Cardiac Transplantation for Adult Congenital Heart Disease in the Modern Era
X. Zeng,¹ R. Vela,² J. Pruszynski,² J. Martinez,² S. Ring,² M. Peltz.²
¹Surgery, University of Texas Southwestern Medical Center, Dallas, TX; ²Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallss, TX.
Background: More patients with congenital heart disease (CHD) are surviving into adulthood and require heart transplantation. These patients historically experienced worse survival early after transplantation.…
2018 American Transplant Congress
Impact of Pre-Transplant Dialysis on ESRD-Free and Patient Survival in Heart Transplant Alone and in Simultaneous Heart/Kidney Transplant Recipients: UNOS Data Analysis
S. Akkina, A. Desai, J. Yoo, S. Hou, R. Parasuraman.
Medicine, Loyola University, Maywood, IL.
It is well known that chronic kidney disease has significant negative impact on post-transplant survival in heart transplant (HTx) recipients. Here we wanted to evaluate…
2018 American Transplant Congress
Outcomes of Subsequent Pregnancies in Female Heart Transplant Recipients
S. Rao,^1,2 D. Armenti,¹ L. Coscia,¹ S. Constantinescu,^1,2 M. Moritz.^1,3,4
¹Transplant Pregnancy Registry International, Gift of Life Institute, Philadelphia, PA; ²Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA; ³Surgery, Lehigh Valley Health Network, Allentown, PA; ⁴Surgery, Morsani College of Medicine, Tampa, FL.
The purpose of this study is to analyze the maternal and newborn outcomes in successive pregnancies in female heart transplant recipients (HT) reported to the…
2018 American Transplant Congress
The Renal Sparing Protocol after Heart Transplant That Keeps Giving
M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, R. Sharoff, J. Kobashigawa.
Cedars Sinai Medical Center, Los Angeles.
Purpose: Calcineurin inhibitors (CNI) such as cyclosporine and tacrolimus are known to cause chronic renal failure. As a result, programs have developed renal-sparing protocols (RSP)…
2018 American Transplant Congress
Solid Organ Transplantation and Data Mining: Risk Factors for Invasive Fungal Disease in Heart Transplant Recipients
N. Barros, D. Xie, C. Yek, T. Liu, X. Li, B. Adams-Huet, J. Martinez, S. Garg, J. Grodin, R. Morelend, A. Amin, F. Aras, J. Thibodeau, P. Mammen, M. Peltz, M. Drazner, W. Ring, R. Haley, R. La Hoz.
UT Southwestern, Dallas, TX.
We created a database of solid organ transplant (SOT) recipients using innovative data mining tools. This study describing the epidemiology of invasive fungal disease (IFD)…
2018 American Transplant Congress
Chronic Narcotic Use Increases Mortality Rates in Heart Transplantation
G. St. John, T. Chamogeorgakis, H. Nemeh, C. Tita, Y. Selektor, D. Lanfear, C. Williams.
Transplant, Henry Ford Hospital, Detroit, MI.
Purpose: In kidney and liver transplantation, chronic narcotic use pre and post-transplant has been associated with an increased risk for rejection and early graft loss.…
2018 American Transplant Congress
Deep Vein Thrombosis in Heart Transplant Patients
G. Bhat, T. Setia, C. Nguyen, I. Balanlayos, A-.G. Roska, A. Andrade, W. Cotts, G. Macaluso, S. Pauwaa, M. Bresticker, A. Tatooles, P. Pappas.
Heart Institute, Advocate Christ Medical Center, Oak Lawn, IL.
Introduction:Deep Vein Thrombosis (DVT) is one of the leading causes of cardiovascular morbidity and mortality. The incidence of DVT is usually higher in the lower…
2018 American Transplant Congress
Single-Cell Analysis of Graft Infiltrating T-Cells in Cardiac Allograft Vasculopathy
M. Habal, A. Myung, H. Yan, S. Rao, S. Lin, P. Colombo, C. Marboe, S. Restaino, A. Han, M. Farr, E. Zorn.
Medicine, Columbia University Medical Center, New York, NY.
Background: Cardiac allograft vasculopathy (CAV) remains a leading cause of death after heart transplant.T-cells are thought to play a central role, yet the mechanism by…
2018 American Transplant Congress
Air Pollution Can Support the Development of Cardiac Allograft Vasculopathy
C. Bara,¹ M. Barten,² D. Boethig,¹ Y. Scheibner,¹ J. Tauber,² H. Reichenspurner,² A. Haverich.¹
¹Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany; ²Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Purpose:Cardiac allograft vasculopathy (CAV) remains one of most important factors leading to graft dysfunction and mortality after heart transplantation (HTx). Thus, the identification of risk…